• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MannKind Corporation

MannKind Corporation

  1. All
  2. Morningstar Articles
  1. Five Consensus Views that Could Prove Wrong in 2015

    Options on this firm's blockbuster cost a little but pay off big.

  2. Makings of a Wide Moat in Diabetes Care

    Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.

  3. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  4. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

©2017 Morningstar Advisor. All right reserved.